Community-based interventions for marginalized populations

Clinical Infectious Diseases

Volumn 38, Issue SUPPL. 5, 2004, Pages

  Mitty, Jennifer Adelson ^a   Flanigan, Timothy P ^a  

^a MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; COCAINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIRBORNE INFECTION; COMMUNITY CARE; COPING BEHAVIOR; DIRECTLY OBSERVED THERAPY; EDITORIAL; EPIDEMIC; HAITI; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH SERVICE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH CARE; METHADONE TREATMENT; MORBIDITY; MORTALITY; NEEDLE; PATIENT COMPLIANCE; POVERTY; PRIORITY JOURNAL; PRISON; SCHIZOPHRENIA; SECONDARY PREVENTION; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SUBSTANCE ABUSE; TUBERCULOSIS; VIRUS TRANSMISSION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMMUNITY HEALTH SERVICES; DIRECTLY OBSERVED THERAPY; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE; POPULATION; RESIDENCE CHARACTERISTICS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 2942560502     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/421398     Document Type: Editorial

References (18)

1. Celentano DD, Vlahov D, Cohn S, Shadle VM, Obasanjo O, Moore RD. Self-reported antiretroviral therapy in injection drug users. JAMA 1998; 280:544-6.
2. Sherer R. Adherence and antiretroviral therapy in injection drug users. JAMA 1998; 280:567-8.
3. Gifford AL, Cunningham WE, Heslin KC, et al. Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med 2002; 346:1373-82.
4. Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis 2001; 33:865-72.
5. Chaulk CP, Kazandijian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the public health tuberculosis guidelines panel. JAMA 1998; 279:943-8.
6. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330:1179-84.
7. Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1993; 42(RR-7):1-8.
8. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med 1995; 333:229-33.
9. Bangsberg DR, Mundy LM, Tulsky JP. Expanding directly observed therapy: tuberculosis to human immunodeficiency virus. Am J Med 2001; 110:664-6.
10. Mitty JA, Stone VE, Sands M, Macalino G, Flanigan T. Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress. Clin Infect Dis 2002; 34:984-90.
11. Lucas G, Lucas GM, Flexner CW, Moore RD. Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden. AIDS Patient Care STDs 2002; 16:527-35.
12. Farmer P, Leandre F, Mukherjee JS, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet 2001; 358:404-9.
13. Centers for Disease Control and Prevention. Increases in HIV diagnosis - 29 states, 1999-2002. MMWR Morb Mortal Wkly Rep 2003; 52:1145-8.
14. Centers for Disease Control and Prevention. Heterosexual transmission of HIV - 29 States, 1999-2002. MMWR Morb Mortal Wkly Rep 2004; 53:125-8.
15. Watts DH, Lambert J, Stiehm ER, et al. Progression of HIV disease among women following delivery. J Acquir Immune Defic Syndr 2003; 33:585-93.
16. Tedaldi E, Willard S, Gilmore J, Holdsworth C, Dix-Lassiter S, Axelrod P. Continuation of postpartum antiretroviral therapy in a cohort of women infected with human immunodeficiency virus. J Assoc Nurses AIDS Care 2002; 13:60-5.
17. Hammert TM, Harmon P, Rhodes W. The burden of infectious diseases among inmates and releasees from correctional facilities. In: The health care needs of soon-to-be released inmates: report to the US Congress National Institute of Justice. Chicago: National Commission on Correctional Health Care, 2002.
18. Wohl DA, Shain L, Adamian M, et al. HIV transmission risk behaviors among HIV-infected individuals released from prison [abstract 36]. In: Program and abstracts of the 10th Conference on Retroviruses and Opportunistic Infections (Boston). Alexandria, VA: Foundation for Retroviruses and Human Health, 2003.